Clinical Trials Logo

Clinical Trial Summary

Erythroferrone (ERFE) is a recently identified iron-regulatory hormone that couples iron homeostasis to erythropoiesis but at this time there are no human data on this hormone in pregnant women and their neonates. The investigators hypothesize that ERFE is a sensitive biomarker of iron deficiency and anemia in pregnancy and neonates, and that it mediates the feedback mechanism to correct iron deficiency and anemia. To address this research gap, the investigators will measure ERFE in maternal serum, umbilical cord serum and placental tissue using an existing biospecimen archive.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04517734
Study type Observational
Source Cornell University
Contact
Status Completed
Phase
Start date April 2006
Completion date December 2017

See also
  Status Clinical Trial Phase
Completed NCT03522428 - Vitamin B12 Pregnancy Supplementation Phase 4
Not yet recruiting NCT06061393 - Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia Phase 4
Recruiting NCT05975125 - The Effect of Vitamin C for Iron Supplementation During Pregnancy With Risk of Anemia N/A
Active, not recruiting NCT05739097 - Prospective Study on Feto-maternal outcoMe In aNemIc womEn
Recruiting NCT03448432 - Prevalence Study of the Etiology of Pregnancy Anemia N/A
Enrolling by invitation NCT04810546 - Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy N/A
Withdrawn NCT03873571 - Adherence of Iron Succinylate Therapy in Pregnancy
Recruiting NCT06434870 - Effect of Spinal Anesthesia in Elective Cesarean Cases on Frontal QRS Angle in Anemic and Non-Anemic Patients
Completed NCT04812821 - Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital